Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs

for
Breast Cancer
Location: Totowa NJ, Philadelphia PA
Sponsor: SpotitEarly

Sex: Female

Age: 18+

Code: NCT07038785

Recruiting

Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study

for
Breast Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 25 - 70+

Code: NCT03408353

Recruiting

Navigation Interventions to Improve Cascade Genetic Testing Among Relatives of Patients With Hereditary Cancer Syndromes

for
Hereditary Malignant Neoplasm, Hereditary Neoplastic Syndrome
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT06927947

Recruiting

Implementing REmote SymPtom mOnitoring and maNagement (RESPONd)

for
Cancer
Location: Edmonton, Red Deer, Calgary
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT07024329

Recruiting

Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors

for
Cancer, Childhood Cancer,
Location: New Haven CT, Trumbull CT
Sponsor: Yale University

Sex: All

Age: 5+

Code: NCT07019259

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

for
Refractory Solid Tumors, Relapsed Solid Tumors,
Location: Boston MA, Philadelphia PA, Houston TX,
Sponsor: Theodore Laetsch

Sex: All

Age: 1 - 30

Code: NCT06721689

Phase 1, Phase 2, Recruiting

Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)

for
Leukemia, Relapsed Leukemia, Chronic Lymphocytic Leukemia,
Location: Boston MA
Sponsor: Jennifer R. Brown, MD, PhD

Sex: All

Age: 18+

Code: NCT06644183

Phase 1, Phase 2, Recruiting

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

for
Malignant Neoplasm
Location: Sherbrooke, New York NY, Hackensack NJ, Montreal,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06979596

Phase 2, Recruiting

A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction

for
Breast Carcinoma
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07047872

Recruiting

Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer

for
NSCLC, Locally Advanced
Location: The Bronx NY
Sponsor: Montefiore Medical Center

Sex: All

Age: 18+

Code: NCT06865339

Phase 2, Recruiting

Two Versus One Week Breast Radiotherapy (RT)

for
Breast Cancer
Location: New York NY
Sponsor: Weill Medical College of Cornell University

Sex: Female

Age: 0+

Code: NCT06960707

Phase 3, Recruiting

Clinical and Genetic Studies of Li-Fraumeni Syndrome

for
Li-Fraumeni Syndrome, Neoplasms, Tp53 Mutations
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT01443468

Recruiting

Patient Priorities for Survivorship Care in Older Breast Cancer Survivors

for
Breast Cancer Survivorship
Location: Houston TX, Bellaire TX
Sponsor: The University of Texas Health Science Center, Houston

Sex: Female

Age: 65 - 70+

Code: NCT06478589

Phase 2, Recruiting

Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Upland CA, Lancaster CA, Duarte CA, Arcadia CA,
Sponsor: City of Hope Medical Center

Sex: Female

Age: 40+

Code: NCT06954831

Phase 2, Recruiting

Implementation of an Oral Chemotherapy Adherence Intervention

for
Solid Tumor, Hematologic Malignancy
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 21+

Code: NCT06989489

Recruiting

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Raleigh NC, Tampa FL, Detroit MI, St Louis MO,
Sponsor: MOMA Therapeutics

Sex: All

Age: 18+

Code: NCT06974110

Phase 1, Recruiting

Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer

for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06434064

Phase 2, Recruiting

Rehabilitation Outcomes Study

for
Cancer, Malignant Tumor
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06674889

Recruiting

Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry

for
Oligometastasis, Metastatic Cancer
Location: Raleigh NC, Cary NC, Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT04085029

Recruiting

A Study of Herbal Supplements in Cancer Survivors With Constipation

for
Constipation, Cancer, Functional Constipation
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07091084

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial